A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease

[1]  Peng Yu,et al.  Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical “disconnection” , 2010, NeuroImage.

[2]  R. Faull,et al.  GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease , 1995, Neuroscience.

[3]  B. Fischl,et al.  White matter pathology isolates the hippocampal formation in Alzheimer's disease , 2010, Neurobiology of Aging.

[4]  Guy Marchal,et al.  Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.

[5]  David S Tuch,et al.  Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures , 2006, Movement disorders : official journal of the Movement Disorder Society.

[6]  Stefan Klöppel,et al.  White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease. , 2008, Brain : a journal of neurology.

[7]  R. Schwarcz,et al.  Excitotoxic models for neurodegenerative disorders. , 1984, Life sciences.

[8]  D. Shear,et al.  Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[9]  Marian DiFiglia,et al.  Huntington Disease , 1998, Journal of neuropathology and experimental neurology.

[10]  Françoise Condé,et al.  Replicating Huntington's disease phenotype in experimental animals , 1999, Progress in Neurobiology.

[11]  C D Good,et al.  The distribution of structural neuropathology in pre-clinical Huntington's disease. , 2002, Brain : a journal of neurology.

[12]  E. Růžička,et al.  MR relaxometry in Huntington's disease: Correlation between imaging, genetic and clinical parameters , 2007, Journal of the Neurological Sciences.

[13]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[14]  Kurt E. Weaver,et al.  Longitudinal diffusion tensor imaging in Huntington's Disease , 2009, Experimental Neurology.

[15]  Yen F. Tai,et al.  Imaging microglial activation in Huntington's disease , 2007, Brain Research Bulletin.

[16]  Hsiao-Fang Liang,et al.  Detecting axon damage in spinal cord from a mouse model of multiple sclerosis , 2006, Neurobiology of Disease.

[17]  Sheng-Kwei Song,et al.  Axial Diffusivity Is the Primary Correlate of Axonal Injury in the Experimental Autoimmune Encephalomyelitis Spinal Cord: A Quantitative Pixelwise Analysis , 2009, The Journal of Neuroscience.

[18]  P. Basser,et al.  Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.

[19]  M. Beal,et al.  Chronic quinolinic acid lesions in rats closely resemble Huntington's disease , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  Hsiao-Fang Liang,et al.  Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum , 2006, Magnetic resonance in medicine.

[21]  Shu-Wei Sun,et al.  Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia , 2003, NeuroImage.

[22]  Paul Suetens,et al.  A Viscous Fluid Model for Multimodal Non-rigid Image Registration Using Mutual Information , 2002, MICCAI.

[23]  Alexander Gerhard,et al.  Microglial activation in presymptomatic Huntington's disease gene carriers. , 2005, Brain : a journal of neurology.

[24]  J. Pedraza-Chaverri,et al.  Time-related changes in constitutive and inducible nitric oxide synthases in the rat striatum in a model of Huntington's disease. , 2007, Neurotoxicology.

[25]  Abraham Z. Snyder,et al.  Assessing optic nerve pathology with diffusion MRI: from mouse to human , 2008, NMR in biomedicine.

[26]  M. Scattoni,et al.  Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington’s disease , 2004, Behavioural Brain Research.

[27]  E. Martínez,et al.  Analysis of chemically-induced alterations of the motor activity in rats. , 1998, Neurotoxicology.

[28]  Jane S. Paulsen,et al.  In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease , 2004, Neurology.

[29]  R. Schwarcz,et al.  II: Excitotoxic models for neurodegenerative disorders , 1984 .

[30]  Elsdon Storey,et al.  Excitotoxin Lesions in Primates as a Model for Huntington's Disease: Histopathologic and Neurochemical Characterization , 1993, Experimental Neurology.

[31]  Sheng-Kwei Song,et al.  Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition , 2004, Neurobiology of Disease.

[32]  A. Alexander,et al.  Diffusion tensor imaging of the brain , 2007, Neurotherapeutics.

[33]  Jan Sijbers,et al.  Nonrigid Coregistration of Diffusion Tensor Images Using a Viscous Fluid Model and Mutual Information , 2007, IEEE Transactions on Medical Imaging.

[34]  P G Bhide,et al.  Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain , 2001, Journal of neuropathology and experimental neurology.

[35]  Simon R. Cherry,et al.  Deficits in Striatal Dopamine D2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease , 2000, Experimental Neurology.

[36]  S. Ferré,et al.  Effects of the systemic administration of kainic acid and NMDA on exploratory activity in rats , 1995, Pharmacology Biochemistry and Behavior.

[37]  F. Fazio,et al.  Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[38]  A. Wauquier,et al.  Episodic barrel rotations induced by intrastriatal injection of quinolinic acid in rats. Inhibition by anticonvulsants , 1988, Pharmacology Biochemistry and Behavior.

[39]  Paolo Guidetti,et al.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease , 2010, Progress in Neurobiology.

[40]  Shu-Wei Sun,et al.  Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging , 2005, Experimental Neurology.

[41]  Jan Sijbers,et al.  On the construction of a ground truth framework for evaluating voxel-based diffusion tensor MRI analysis methods , 2009, NeuroImage.

[42]  A. Aron,et al.  Contrasting gray and white matter changes in preclinical Huntington disease , 2010, Neurology.

[43]  David Broadhurst,et al.  Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. , 2006, Brain : a journal of neurology.

[44]  M. DiFiglia,et al.  Intrastriatal Injections of Quinolinic Acid or Kainic Acid: Differential Patterns of Cell Survival and the Effects of Data Analysis on Outcome , 1993, Experimental Neurology.

[45]  M. Vivó,et al.  Lesion of substantia nigra pars compacta by the GluR5 agonist ATPA , 2002, Brain Research.

[46]  A. Leemans,et al.  Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract , 2009, NMR in biomedicine.

[47]  Timothy Edward John Behrens,et al.  In vivo evidence for the selective subcortical degeneration in Huntington's disease , 2009, NeuroImage.

[48]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[49]  Guy B. Williams,et al.  Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. , 2010, Brain : a journal of neurology.

[50]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[51]  L. Massieu,et al.  Excitotoxic neuronal death and the pathogenesis of Huntington's disease. , 2008, Archives of Medical Research.

[52]  G. Egan,et al.  Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease , 2008, Brain Research Reviews.